3-(4-tert-Butoxycarbonylamino-phenyl)-3-oxo-propionic acid ethyl ester, 95%, 100mg

Matracci tarati classe A Vetro trasparente, 25 ml, 10/19, 2 unità, 2 Pezzo(i)

1-Fluoro-4-iodo-2-isopropylbenzene, 97.0%, 1g

4-Aminotetrahydro-N-methyl-2H-pyran-4-carboxamide, 97%, 5g

4-Chloro-6-cyclopropylpyrimidine, 95.0%, 1g

(R)-(-)-2-Amino-1-phenylethanol>96.0%(HPLC)1g

4-Bromo-3,5-difluorophenol, 98.0%, 25g

(6-Chloroimidazo[1,2-b]pyridazin-3-yl)methanol, 96.0%, 1g

Piano obiettivo per contrasto di fase PLPH 10x/0,25

(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-Bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol, 98%, 250mg

4-Bromo-3-methyl-isothiazol-5-ylamine, 95.0%, 1g

(R)-1-Benzyl 3-ethyl piperidine-1,3-dicarboxylate, 95.0%, 5g

2-(1H-1,2,4-triazol-1-yl)aniline, 98%, 250mg